1 Department of Outcomes Research, St. George's Vascular Institute, London, UK ; 2 Department of Thoracic and Vascular Surgery, A de Villeneuve Hospital, Montpellier, France.
Ann Cardiothorac Surg. 2014 May;3(3):223-33. doi: 10.3978/j.issn.2225-319X.2014.05.12.
Available data on outcomes of combined proximal stent-grafting with distal bare stenting for management of aortic dissection are limited. The objective of this study was to provide a systematic review of outcomes of this approach.
Studies involving combined proximal stent-grafting with distal bare stenting for management of aortic dissection were systematically searched and reviewed through MEDLINE databases.
A TOTAL OF FOUR STUDIES WERE INCLUDED: 108 patients treated for management of acute (n=54) and chronic (n=54) aortic dissection. The technical success rate was 95.3% (range, 84-100%). The 30-day mortality rate was 2.7% (range from 0% to 5%). The morbidity rate occurring within 30 days was 51.8% (range from 0% to 65%) and included stroke (2.7%), paraplegia (2.7%), retrograde dissection (1.8%), renal failure (14.8%), severe cardiopulmonary complications (5.5%) and bowel ischemia (0.9%). The incidence of type I endoleak was 9.2% (10/108). During follow-up, 5 (4.6%) deaths were related to aortic rupture or aortic repair. Mean re-intervention rate was 12.9%. Two cases (1.9%) of delayed retrograde type A dissection and one case of aortobronchial fistula (0.9%) were reported. The most common delayed complication was thoracic stent-graft migration (4.7%). The rate of device failure was 9.2%. Favorable aortic remodeling was observed: studies reporting midterm follow-up of the true lumen demonstrated a high rate of both false lumen regression and true lumen expansion. At 12 months, complete false lumen thrombosis was observed at the thoracic level in 70.4% and at the abdominal level in 13.5% of patients.
Combined proximal stent-grafting with distal bare stenting appears to be a feasible approach for the management of Type B aortic dissection. Although this approach clearly improved true lumen perfusion and diameter, it failed to completely suppress false lumen patency. However, it should be acknowledged that contemporary data on this approach is limited to small studies with variable results.
关于近端覆膜支架与远端裸支架联合治疗主动脉夹层的结果数据有限。本研究的目的是对这种方法的结果进行系统评价。
通过 MEDLINE 数据库系统地搜索和回顾了涉及近端覆膜支架与远端裸支架联合治疗主动脉夹层的研究。
共纳入 4 项研究:108 例急性(n=54)和慢性(n=54)主动脉夹层患者接受治疗。技术成功率为 95.3%(范围 84-100%)。30 天死亡率为 2.7%(范围 0-5%)。30 天内发生的发病率为 51.8%(范围 0-65%),包括卒中(2.7%)、截瘫(2.7%)、逆行夹层(1.8%)、肾衰竭(14.8%)、严重心肺并发症(5.5%)和肠缺血(0.9%)。Ⅰ型内漏的发生率为 9.2%(10/108)。随访期间,5 例(4.6%)死亡与主动脉破裂或主动脉修复有关。平均再介入率为 12.9%。报告了 2 例(1.9%)迟发性逆行 A 型夹层和 1 例主动脉支气管瘘(0.9%)。最常见的迟发性并发症是胸主动脉支架移植物迁移(4.7%)。设备失败率为 9.2%。观察到有利的主动脉重塑:报告中期随访真腔的研究显示,假腔再通和真腔扩张的比例均较高。在 12 个月时,70.4%的患者在胸段和 13.5%的患者在腹段观察到完全的假腔血栓形成。
近端覆膜支架与远端裸支架联合治疗 B 型主动脉夹层似乎是一种可行的方法。尽管这种方法明显改善了真腔灌注和直径,但未能完全抑制假腔通畅。然而,应该承认,关于这种方法的当代数据仅限于结果存在差异的小型研究。